Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.91% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.04% |
| 4 | Consumer Discretionary | 4.86% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
PUT
Bath & Body Works
BBWI
$3.84B
| $10.1M | 0.01% |
392,624
+94,631
| +32% | +$1.93M |
|
|
1027
Bath & Body Works
BBWI
$3.84B
| $10.1M | 0.01% |
392,579
-314,766
| -44% | -$6.43M |
|
1028
Western Union
WU
$2.19B
| $10.1M | 0.01% |
470,184
+55,848
| +13% | +$1.27M |
|
1029
PUT
Boston Scientific
BSX
$74B
| $10.1M | 0.01% |
263,700
+247,200
| +1,498% | +$9.53M |
|
1030
Norwegian Cruise Line
NCLH
$8.54B
| $10.1M | 0.01% |
588,258
+64,002
| +12% | +$1.01M |
|
1031
Pultegroup
PHM
$25.2B
| $10M | 0.01% |
216,556
+10,908
| +5% | +$467K |
|
|
JNPR
1032
DELISTED
Juniper Networks
JNPR
| $10M | 0.01% |
465,295
+133,464
| +40% | +$3.16M |
|
1033
Sarepta Therapeutics
SRPT
$1.88B
| $10M | 0.01% |
71,185
-106
| -0.1% | -$16.1K |
|
1034
Arch Capital
ACGL
$33.6B
| $9.96M | 0.01% |
340,325
-64,560
| -16% | -$1.97M |
|
1035
CALL
Applied Materials
AMAT
$416B
| $9.95M | 0.01% |
167,300
+148,700
| +799% | +$9.19M |
|
|
JJC
1036
DELISTED
iPath Series B Bloomberg Copper Subindex Total ReturnSM ETN
JJC
| $9.87M | 0.01% |
645,000
| – | – |
|
1037
CALL
iShares MSCI South Korea ETF
EWY
$25.8B
| $9.86M | 0.01% |
150,900
| – | – |
|
1038
PUT
Merck
MRK
$322B
| $9.8M | 0.01% |
123,874
+29,030
| +31% | +$2.27M |
|
|
CUB
1039
DELISTED
Cubic Corporation
CUB
| $9.79M | 0.01% |
168,349
+97,475
| +138% | +$4.58M |
|
1040
Tandem Diabetes Care
TNDM
$1.61B
| $9.74M | 0.01% |
85,779
-15,701
| -15% | -$1.65M |
|
1041
PUT
Lyft
LYFT
$6.69B
| $9.73M | 0.01% |
353,200
-77,600
| -18% | -$2.31M |
|
1042
News Corp Class A
NWSA
$15.4B
| $9.68M | 0.01% |
690,563
-237,255
| -26% | -$3.31M |
|
1043
CALL
MongoDB
MDB
$35B
| $9.68M | 0.01% |
41,800
| – | – |
|
1044
PUT
iShares MSCI Mexico ETF
EWW
$1.89B
| $9.64M | 0.01% |
288,900
+159,200
| +123% | +$5.26M |
|
|
1045
PUT
iShares MSCI South Korea ETF
EWY
$25.8B
| $9.61M | 0.01% |
147,100
| – | – |
|
1046
TransUnion
TRU
$15.4B
| $9.58M | 0.01% |
113,842
+3,701
| +3% | +$320K |
|
1047
Molson Coors Class B
TAP
$7.83B
| $9.51M | 0.01% |
283,473
+70,223
| +33% | +$2.53M |
|
1048
HEICO Corp
HEI
$50.9B
| $9.49M | 0.01% |
90,714
-8,943
| -9% | -$924K |
|
1049
SS&C Technologies
SSNC
$18.8B
| $9.49M | 0.01% |
156,857
+48,323
| +45% | +$2.89M |
|
1050
Allegion
ALLE
$14.3B
| $9.47M | 0.01% |
95,802
-8,018
| -8% | -$814K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.